Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds for the treatment of gastrointestinal, ophthalmic, vascular and respiratory diseases as well as other disorders for which there are significant unmet medical needs, underserved patients and significant commercial potential. For further information, visit the company’s Web site at www.sucampo.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: